165 related articles for article (PubMed ID: 27488685)
1. Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study.
De Icco R; Cucinella L; De Paoli I; Martella S; Sances G; Bitetto V; Sandrini G; Nappi G; Tassorelli C; Nappi RE
J Headache Pain; 2016 Dec; 17(1):70. PubMed ID: 27488685
[TBL] [Abstract][Full Text] [Related]
2. Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.
Merki-Feld GS; Epple G; Caveng N; Imthurn B; Seifert B; Sandor P; Gantenbein AR
J Headache Pain; 2017 Aug; 18(1):91. PubMed ID: 28842849
[TBL] [Abstract][Full Text] [Related]
3. Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?
Merki-Feld GS; Imthurn B; Dubey R; Sándor PS; Gantenbein AR
J Obstet Gynaecol; 2017 Apr; 37(3):338-341. PubMed ID: 28129717
[TBL] [Abstract][Full Text] [Related]
4. Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine - temporal relation to bleeding and hormone withdrawal: a prospective diary-based study.
Merki-Feld GS; Caveng N; Speiermann G; MacGregor EA
J Headache Pain; 2020 Jun; 21(1):81. PubMed ID: 32580694
[TBL] [Abstract][Full Text] [Related]
5. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
6. Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements.
Macgregor EA; Hackshaw A
J Fam Plann Reprod Health Care; 2002 Jan; 28(1):27-31. PubMed ID: 16259812
[TBL] [Abstract][Full Text] [Related]
7. Medication overuse reinstates conditioned pain modulation in women with migraine.
Guy N; Voisin D; Mulliez A; Clavelou P; Dallel R
Cephalalgia; 2018 May; 38(6):1148-1158. PubMed ID: 28825315
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives in migraine.
Allais G; Gabellari IC; De Lorenzo C; Mana O; Benedetto C
Expert Rev Neurother; 2009 Mar; 9(3):381-93. PubMed ID: 19271947
[TBL] [Abstract][Full Text] [Related]
9. Treating migraine with contraceptives.
Allais G; Chiarle G; Sinigaglia S; Airola G; Schiapparelli P; Bergandi F; Benedetto C
Neurol Sci; 2017 May; 38(Suppl 1):85-89. PubMed ID: 28527064
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives in migraine therapy.
Allais G; Castagnoli Gabellari I; De Lorenzo C; Mana O; Benedetto C
Neurol Sci; 2011 May; 32 Suppl 1():S135-9. PubMed ID: 21533729
[TBL] [Abstract][Full Text] [Related]
11. Sex hormones and headache.
Silberstein SD
Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
[TBL] [Abstract][Full Text] [Related]
12. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
Coffee AL; Sulak PJ; Hill AJ; Hansen DJ; Kuehl TJ; Clark JW
J Womens Health (Larchmt); 2014 Apr; 23(4):310-7. PubMed ID: 24450487
[TBL] [Abstract][Full Text] [Related]
13. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke.
Champaloux SW; Tepper NK; Monsour M; Curtis KM; Whiteman MK; Marchbanks PA; Jamieson DJ
Am J Obstet Gynecol; 2017 May; 216(5):489.e1-489.e7. PubMed ID: 28034652
[TBL] [Abstract][Full Text] [Related]
14. [Migraine and contraception].
Cappy H; Lucas C; Catteau-Jonard S; Robin G
Gynecol Obstet Fertil; 2015 Mar; 43(3):234-41. PubMed ID: 25727163
[TBL] [Abstract][Full Text] [Related]
15. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).
Sacco S; Merki-Feld GS; Ægidius KL; Bitzer J; Canonico M; Gantenbein AR; Kurth T; Lampl C; Lidegaard Ø; Anne MacGregor E; MaassenVanDenBrink A; Mitsikostas DD; Nappi RE; Ntaios G; Paemeleire K; Sandset PM; Terwindt GM; Vetvik KG; Martelletti P;
J Headache Pain; 2018 Aug; 19(1):76. PubMed ID: 30171365
[TBL] [Abstract][Full Text] [Related]
16. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice.
Loder EW; Buse DC; Golub JR
Headache; 2005 Mar; 45(3):224-31. PubMed ID: 15836597
[TBL] [Abstract][Full Text] [Related]
17. Safety of hormonal contraceptives among women with migraine: A systematic review.
Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study.
Merki-Feld GS; Sandor PS; Nappi RE; Pohl H; Schankin C
Acta Neurol Belg; 2022 Apr; 122(2):401-409. PubMed ID: 33928470
[TBL] [Abstract][Full Text] [Related]
19. The relationship between vascular headaches and low-dose oral contraceptives.
Karsay K
Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
[TBL] [Abstract][Full Text] [Related]
20. The inconvenience due to women's monthly bleeding (ISY) survey: a study of premenstrual symptoms among 5728 women in Europe.
Lete I; Häusler G; Pintiaux A; Jamin C; Nappi RE; Fiala C; Chabbert-Buffet N; Lobo P
Eur J Contracept Reprod Health Care; 2017 Oct; 22(5):354-359. PubMed ID: 29157023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
